Global study probes patient views on gene therapy for hemophilia b

NCT ID NCT05044845

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study interviewed 150 people with hemophilia B, their caregivers, and healthcare workers from around the world to learn what they know and how they feel about gene therapy. The goal is to create better educational materials and improve the consent process, especially in countries with limited resources. No treatment was given—only interviews were conducted.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA B are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

hemophilia B

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Civil Service Hospital

    Kathmandu, Nepal

  • Hospital Dos De Mayo

    Lima, Peru

  • National Hospital of Sri Lanka

    Colombo, 01000, Sri Lanka

  • National Institute of Hematology and Blood Transfusion

    Hanoi, Vietnam

  • Ramathibodi Hospital

    Bangkok, 10400, Thailand

  • St. Jude Children's Research Hospital

    Memphis, Tennessee, 38105, United States